Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × Ifosfamide × Clear all

Carcinoma, Non-Small-Cell Lung

NCT00003657 2017-01-20

High-dose ICE With Amifostine

CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00622349 2013-01-30

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

Phase 3 Completed

707 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01749072 2012-12-13

Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients

Phase 2 Unknown

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00148395 2008-04-22

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Phase 3 Completed

280 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma

High-dose ICE With Amifostine

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.